Dynamic imaging of emerging resistance during cancer therapy. - Wikidata - awgldk - TriplyDB

Dynamic imaging of emerging resistance during cancer therapy.

Dynamic imaging of emerging resistance during cancer therapy.

http://www.wikidata.org/entity/Q31038951

about

Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions Sodium MRI of glioma in animal models at ultrahigh magnetic fields.Diffusion MRI in early cancer therapeutic response assessment.The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib.ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma.Applications of molecular imaging.Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme.Whole body diffusion weighted MRI--a new view of myeloma.DW-MRI as a Predictive Biomarker of Radiosensitization of GBM through Targeted Inhibition of Checkpoint Kinases.Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101 Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.Diffusion-Weighted MRI as a Biomarker of Tumor Radiation Treatment Response Heterogeneity: A Comparative Study of Whole-Volume Histogram Analysis versus Voxel-Based Functional Diffusion Map Analysis Pharmacotherapy for adults with tumors of the central nervous system.Early tumor development captured through nondestructive, high resolution differential phase contrast X-ray imaging.Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers.

P2860

Q26774355-52405E6D-E345-4F64-9666-507214BF1F69 Q30980381-137B362D-0E56-4910-A7CD-C2DF2D7FD46D Q31037179-54C62536-E558-479C-BDE2-630061EEA59A Q31043513-A18E633D-6937-4929-9B8C-B1FE337BF948 Q31140219-A2D653C7-331F-47DE-8E87-2DF79960E0F7 Q33414714-7C015586-7884-48B2-9E7C-333E74C4163F Q33584285-2CF8518E-7B30-4B43-BCA4-BE4E26C17BEC Q33989239-1EE916D0-3126-4B1D-9333-F00EF00FA74B Q34132894-7B4A567A-20B0-4963-8A2B-56CD66B120E0 Q34712780-0F5390D7-1528-4479-A56E-209ECCA83338 Q35082412-CB900A38-A8D5-428F-81B8-EFD820C01A23 Q35698555-377DBBF2-B157-427D-97A9-CFBD53753914 Q36364358-5DCF7012-D9FB-4E32-AAE4-308936A8430C Q36532924-1883C631-5532-4922-AB2C-AD158035FD71 Q36723763-CF6E3673-AB60-421E-875C-9C446AA7E222 Q36815253-268554FE-2F10-4FBA-83C2-4D98AEC65CED Q37182194-9F987107-C996-45E8-8302-9E2ECB94D042 Q37236015-AF09D10E-3664-48A1-B423-A803AF45449A Q37353276-12F0785F-6D16-4B67-96B9-F83159D6E985 Q37586513-A37638B2-1BCA-4ECF-9909-F2573A035977 Q39747261-171EEDC3-5A08-4A5B-8D72-F26814615B2F

P2860

Dynamic imaging of emerging resistance during cancer therapy.

http://www.wikidata.org/entity/Q31038951

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Dynamic imaging of emerging resistance during cancer therapy.

@ast

Dynamic imaging of emerging resistance during cancer therapy.

@en

type

label

Dynamic imaging of emerging resistance during cancer therapy.

@ast

Dynamic imaging of emerging resistance during cancer therapy.

@en

prefLabel

Dynamic imaging of emerging resistance during cancer therapy.

@ast

Dynamic imaging of emerging resistance during cancer therapy.

@en

P1433

Q31038951-CBF47ED7-A95B-4043-8ECF-D3BE2B383813

P1476

Q31038951-7CB5121F-F3F8-4E73-A346-B20C78236AE3

P2093

Q31038951-05943981-78E6-47F2-B9C1-54704DDC73EB

Q31038951-6501B459-C4F3-4943-8243-B6C5FDFBB3C7

Q31038951-905EB568-053B-4761-B82E-A004BB59B4F6

Q31038951-97CFA211-3152-44D0-AC92-FD2D95D2709F

Q31038951-A549D11F-8BD4-427C-9A0C-57F64AAD7868

Q31038951-B8437DCD-7200-46ED-AAD2-C9EDACA5444E

Q31038951-BEE6EF69-6B36-4841-B6E5-817CB18CAAD7

Q31038951-C0C5D350-AF7C-4AD9-AD37-FE97A0CA59FB

Q31038951-E0703A14-2911-40AA-BF97-F692900CE4E5

Q31038951-F4EF9500-123D-4808-8453-B91ACDD9BA9F

P304

Q31038951-EFAEFFC7-9E39-432C-87C3-8F9E0ABC3D00

P31

Q31038951-0A8A7DF3-9BC4-4AD9-89D7-63B79FC2A7AF

P356

Q31038951-53104110-0A08-4C4D-BA64-29E93D1EB0F0

P407

Q31038951-222A78EF-A9E8-4223-9859-7491402834E2

P433

Q31038951-C4D80CC2-BDDC-4D18-A9DC-0FECD444DCEF

P478

Q31038951-FBCDB3CB-D5D6-46F0-94EE-EF32C272FF5C

P50

Q31038951-8A05BEF0-7D18-4AB7-8219-66E70746E8D5

P577

Q31038951-EC359066-7F73-41A5-97EB-AC46D2E26F9A

P698

Q31038951-22E6DE1D-ACCB-43A4-942A-47B487576358

P356

0008-5472.CAN-05-3205

P1433

Cancer Research

P1476

Dynamic imaging of emerging resistance during cancer therapy.

@en

P2093

Alnawaz Rehemtulla

http://www.w3.org/2001/XMLSchema#string

Benjamin A Hoff

http://www.w3.org/2001/XMLSchema#string

Bradford A Moffat

http://www.w3.org/2001/XMLSchema#string

Brian D Ross

http://www.w3.org/2001/XMLSchema#string

Charles R Meyer

http://www.w3.org/2001/XMLSchema#string

Daniel E Hall

http://www.w3.org/2001/XMLSchema#string

Kuei C Lee

http://www.w3.org/2001/XMLSchema#string

Richard V Mazurchuk

http://www.w3.org/2001/XMLSchema#string

Surabhi Sharma

http://www.w3.org/2001/XMLSchema#string

Timothy D Johnson

http://www.w3.org/2001/XMLSchema#string

P304

4687-4692

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-05-3205

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Thomas L Chenevert

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16651420

http://www.w3.org/2001/XMLSchema#string